Philippines Usa India city Hyderabad covid-19 vaccine SEC Philippines Usa India city Hyderabad

SEC to take decision on antiviral Covid pill Molnupiravir today. Details here

Reading now: 396

ANI. According to the sources, almost 10 pharma companies have completed clinical trials of antiviral pills. The antiviral pill has shown a 30 per cent reduction in hospitalisation and will be useful in the treatment of Covid-19.

The SEC will review the Serum Institute of India's Covovax, the WHO has recently granted emergency use listening (EUL) to Covovax.

The US-based Novovax and Serum Institute of India has already received EUA for these vaccines in the Philippines. The SEC will also review data of the Corbevax vaccine which is produced by Hyderabad based pharmaceutical firm Biological E.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News